supported in part by the Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support (No. ZLRK202325);a grant from National Key R&D Program of China (No. 2018YFC 1313105)。
Gastric cancer is a global public health burden, nearly one million new cases are diagnosed per year worldwide, of which 44% of cases occur in China. The prognosis of gastric cancer varies remarkably by the stage of c...
Objective:Integration of risk stratification into fecal immunochemical test(FIT)might aid in the suboptimal detection of advanced neoplasms by FIT in colorectal cancer(CRC)screening.A comparative study was conducted t...
This study was sponsored by National Key R&D Program of China(No.2O18YFC13131OO);Sanming Project of Medicine in Shenzhen(No.SZSM201911015);CAMS Innovation Fund for Medical Sciences(CIFMS)(No.2019-I2M-2-004).
Objective:National Health Commission of the People's Republic of China collaborated with many ministries and commissions government and initiated a population-based cancer screening program in high-risk area of rural ...
the Chinese Academy of Medical Sciences Initiative for Innovative Medicine(No.2016-I2M-1-019);the National Natural Science Foundation of China(No.81322040)。
Objective:The accuracy of colposcopy-guided biopsy is key to the success of colposcopic triage in cervical cancer screening programs.However,there is no widely adopted biopsy guideline up to date.Our study aimed to de...
supported by the National Key R&D Program of China (No. 2018YFC1313100);the Special Fund for Health Research in the Public Interest (No. 201612M-2-004)
Objective: : China have implemented population-based esophageal cancer(EC) screening programs, however,the participant rates were relatively low. This study was conducted to examine the association between cancer prev...
Objective: In this study, we aimed to estimate the updated incidence and mortality of primary bone cancers based on population-based cancer registration data in 2014, collected by the National Central Cancer Registry ...
supported by grants from the Beijing Young Talent Program (No.2016000021469 G189);Special Fund for Health Research in the Public Interest (No.201502001);CAMS Innovation Fund for Medical Sciences (CIFMS) (No.2016-12M-2-004)
Objective: In this study,we aimed to estimate the updated incidence and mortality rate of stomach cancer based on the cancer registration data in 2014,collected by the National Central Cancer Registry of China(NCCRC...
supported by the National Natural Science Foundation of China (No. 81171989, 30801346);National Basic Research Program of China (973 Program: 2010CB529303);the Capital Health Research and Development of Special (2014-2-1022)
Objective: To identify serum biomarkers that may predict the short or long term outcomes of anti-Helicobacter gylori (H. pylori) treatment, a follow-up study was performed based on an intervention trial in Linqu Co...
granted by the National Natural Science Foundation of China (No.81241091)
Objective: To evaluate the feasibility of DNA image cytometry (DNA-ICM) as a primary screening method for esophageal squamous cell cancer (ESCC). Methods: A total of 5,382 local residents aged 40-69 years from t...
Objective: To analyze the incidence of cancer during 2008-2012 in Beijing, China, and compare the cancer spectrum with that during 1998-1999. Methods: Data from the Beijing Cancer Registry (BCR), which covered 12 ...